α-Pyrrolidinoheptaphenone
Clinical data | |
---|---|
Other names | α-PHPP; alpha-PHPP; alpha-Pyrrolidinoheptiophenone; alpha-Pyrrolidinoheptanophenone; PV-8; PV8; Aphpp; A-PHPP |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C17H25NO |
Molar mass | 259.393 g·mol−1 |
3D model (JSmol) | |
| |
|
α-Pyrrolidinoheptaphenone (PV8, α-PEP, α-PHPP, Aphpp, A-PHPP) is a designer drug of the pyrrolidinophenone class of cathinones. It is the higher homolog of α-pyrrolidinohexiophenone (α-PHP).
In the United States, α-pyrrolidinoheptaphenone is a Schedule I Controlled Substance.
See also
Categories: